Starting from the 4-amino-3-(1,3-diphenyl-1H-pyrazol-4-yl)-4,5-dihydro-[1,2,4] triazole-5(1H)-thione 2, a series of new [1, 3, 4] thiadiazoles 3, 4, 7 and [1,3,4] thiadiazines 8, 10, 11, 12, 14 were prepared. Also, [1, 3, 4] thiadiazepines 16-18 could be synthesized. Some of the newly prepared compounds were evaluated for their antiviral potential.
Introduction
Recently, it was reported that the [1, 2, 4] triazolo [3,4-b] [1, 3, 4] thiadiazoles and [1, 2, 4] triazolo [3,4-b] [1, 3, 4] thiadiazines possess antimicrobial activities. 1 Also, 6-substituted 3-(1-adamantyl)-1,2,4-triazolo [3,4-b] [1, 3, 4] thiadiazoles have been evaluated for their antiviral activity. 2 The [1, 2, 4] triazoles and [1, 3, 4] thiadiazoles are known for their broad-spectrum of biological activities and many other uses. [3] [4] [5] [6] [7] Moreover, the triazolothiadiazoles substituted in the 3 and 6
positions by aryl, alkyl or heterocyclic moiety possess pharmacological activity such as antibacterial, 8 anti-inflammatory, 9 herbicidal 10 and anti-HIV-1 effects. 11 On the other hand, it has been reported that certain compounds bearing a thiadiazole and 1,2,4-triazole nucleus possess significant anti-inflammatory activity. 5, [12] [13] [14] [15] In addition, it was mentioned that [1, 3, 4] thiadiazoles exhibit various biological activities possibly due to the presence of the =N-C-S moiety. 16 The synthesis of triazoles fused to another heterocyclic ring has attracted particular attention due to their diverse applications as antibacterial, antidepressant, antiviral, antitumoral and antiinflammatory agents, pesticides, herbicides, lubricant and analytical reagents. 16, 17 A number of triazoles fused to thiadiazines or thiadiazoles are incorporated into a wide variety of therapeutically important compounds possessing a broad spectrum of biological activities. [17] [18] [19] [20] In
Results and Discussion
The starting material 4-amino-3-(1,3-diphenyl-1H-pyrazol-4-yl)-4,5-dihydro-[1,2,4]triazole-5(1H)-thione 2 was prepared in good yield: by the reaction of the oxadiazole thione 1 with hydrazine hydrate. The latter compound is useful intermediate for the synthesis of triazolothiadiazoles, triazolothiadiazines and triazolothiadiazepines. The amino and mercapto groups are ready-made nucleophilic centers for the synthesis of condensed heterocyclic rings. 1 Thus, an attempt to prepare the oxo-analog of 4 by treatment of 2 with ethyl chloroformate in dry benzene was unsuccessful and the product obtained was identified as the S-substituted derivative 5 which could not be cyclized into 3 on boiling in pyridine. However, compound 3 could be obtained via the interaction of amino thione 2 with 1,1`-carbonyldiimidazole (CDI) in dry dioxane. Treatment of 3 with P 2 S 5 in dry pyridine resulted in the formation of the thione derivative 4. This latter compound could be obtained directly by the reaction of 2 with carbon disulphide in ethanolic KOH (Scheme 1). Treatment of triazolethione 2 with acetyl-or benzoyl chloride in refluxing dioxane did not afford the bicyclic structure triazolothiadiazoles 7a,b but gave the acetyl-or benzoyl amino derivatives 6a,b respectively. Compounds 6a,b could be smoothly cyclidehydrated by boiling in phosphoryl chloride affording the [1, 2, 4] triazolo [3,4-b] [1, 3, 4] thiadiazoles 7a,b in good yield. It is worthy to note that compound 7a could be obtained, in a rather better yield: (82 %), directly by the reaction of 2 with acetic acid in boiling phosphoryl chloride. The IR spectrum of the latter compound showed no NH bands and the 1 H NMR spectrum showed a singlet at 2.71 ppm corresponding to the methyl substituent at position 6 (Scheme 2). From the above reactions we could conclude that the cyclidehydration could only occur in the presence of phosphoryl chloride; the acid chlorides under the used reaction conditions could only give the corresponding actyl(benzoyl)amino derivatives. Treatment of the amino thione 2 with ethyl chloroacetate gave a product whose NMR spectrum showed a signal corresponding to the amino group at 4.48 ppm, a quartet corresponding to (CH 2 CH 3 ) at 4.18 ppm, a singlet assigned to (CH 2 ) at 3.97 ppm, and a triplet assigned to (CH 2 CH 3 ) at 1.27 ppm. This proves the structure 10 and rules out the possible formation of 12. An attempt to cyclize the amino triazole 10 into the corresponding triazolothiadiazinone 12 by heating in refluxing pyridine was unsuccessful. When choroacetic acid was used instead of its ester in the former reaction, the product was identified as the amino acid 11 which could be cyclized into triazolothiadiazinone 12 in boiling phosphoryl chloride (Scheme 4) . Furthermore, treatment of the amino thione 2 with oxalyl chloride in dry benzene afforded the corresponding triazolothiadiazine-6,7-dione 13. Also, its interaction with bromo diethylmalonate led to the formation of the thiadiazine-7-carboxylic acid ethyl ester 14. Whereas, reaction of compound 2 with methyl-2-bromopropionate gave the corresponding S-substituted amino triazole 15 (Scheme 5) . Finally, all the trials to synthesize the triazolo thiadiazepines 19-21 by the reaction of the thione 2 with bifunctional reagents, pentane-2,4-dione, benzoyl acetone and 5-chloro-3-methyl pyrazole-4-carboxyldehyde were unsuccessful (Scheme 7). 
4-Benzoylamino-3-(1,3-diphenyl-1H-pyrazol-4-yl)-4,5-dihydro-[1,2,4]triazole-5(1H)-thione (6b

General procedure for the synthesis of compounds (7a,b). Method a.
A mixture of 6a,b (1 mmol) and phosphoryl chloride (10 mL) was heated under reflux for 2 h. After removing the excess of phosphoryl chloride under reduced pressure, an icewater mixture was added to the residue with vigorous stirring. The reaction mixture was neutralized with ammonium hydroxide and the solid precipitate formed was filtered and recrystallized from ethanol to give 7a,b. Method b. A mixture of 2 (334 mg, 1 mmol) and acetic acid (60 mg, 1 mmol) in phosphoryl chloride (10 mL) was heated under reflux for 2 h. After cooling, the solvent was removed under reduced pressure and an ice-water mixture was added to the residue with stirring. The reaction mixture was neutralized with ammonium hydroxide and the solid precipitate formed was filtered and recrystallized from ethanol to give 7a. mp. and mixed mp. with a sample obtained by the above procedure are identical. >80  >80  >80  >80  >80  400  10  >80  >80  >80  >80  >80  400  11  >16  >16  >16  >16  >16  80  12  >80  >80  >80  80  >80  400  13  >80  >80  >80  >80  >80  400  14  >80  >80  >80  >80  >80  400  16  >16  >16  >16  >16  >16  80  17  >80  >80  >80  >80  >80  400  18  >400  >400  80 >16  >16  80  10  >80  >80  >80  400  11  >16  >16  >16  80  12  >80  48  >80  400  13  >80  >80  >80  400  14  >16  >16  >16  ≥80  16  >16  >16  >16  80  17  >16  >16  >16  80  18 400 >400 >400 ≥400 Brivudin >400 >400 400 >400 (S)-DHPA 80 48 48 >400 Ribavirin >16  >16  >16  >16  80  8  >16  >16  >16  >16  >16  80  9a  >16  >16  >16  >16  >16  80  9b  >16  >16  >16  >16  >16  ≥16  10  >80  >80  >80  >80  >80  400  11  >16  >16  >16  >16  >16  80  12  >80  >80  >80  >80  >80  400  13  >16  >16  >16  >16  >16  80  14  >16  80  >16  >16  >16  400  16  >16  >16  >16  >16  >16  80  17  >16  80  >16  >16  >16  400  18 >400 >400 >400 >400 >400 >400 Brivudin >400 >400 >400 >400 >400 >400 (S)-DHPA 80 >400 400 80 80 >400 Ribavirin a Required to cause a microscopically dateable alteration of normal cell morphology. b Required to reduce virus-induced cytopathogenicity by 50 %.
3-(1,3-Diphenyl-1H-pyrazol-4-yl)-6-methyl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole (7a
